Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cerny

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 1, 1995
[Successful treatment of a case of cutaneous Langerhans cell granulomatosis with 2-chlorodeoxyadenosine and thalidomide]S Dallafior, P Pugin, T Cerny, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2009
Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lungA Omlin, G D'Addario, S Gillessen, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityT Cerny, A Graf, P Rohner, et al.
The American Journal of Hospice & Palliative Care|November 22, 2013
Spiritual experiences of transcendence in patients with advanced cancerM Renz, M Schuett Mao, A Omlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Primary cervical malignant teratoma with a rib metastasis in an adult: five-year survival after surgery and chemotherapy. A case report with a review of the literatureC Als, H Laeng, T Cerny, et al.
Cancer Research|February 1, 1989
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinomaM J Lind, J M Margison, T Cerny, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapyB H Lauterburg, T Nguyen, B Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristicsK Buser, F Joncourt, H J Altermatt, et al.
Helvetica Chirurgica Acta|June 1, 1989
[Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma]M Rentsch, T Cerny, J Richner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|August 1, 1995
[Successful treatment of a case of cutaneous Langerhans cell granulomatosis with 2-chlorodeoxyadenosine and thalidomide]S Dallafior, P Pugin, T Cerny, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2009
Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lungA Omlin, G D'Addario, S Gillessen, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibilityT Cerny, A Graf, P Rohner, et al.
The American Journal of Hospice & Palliative Care|November 22, 2013
Spiritual experiences of transcendence in patients with advanced cancerM Renz, M Schuett Mao, A Omlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Primary cervical malignant teratoma with a rib metastasis in an adult: five-year survival after surgery and chemotherapy. A case report with a review of the literatureC Als, H Laeng, T Cerny, et al.
Cancer Research|February 1, 1989
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinomaM J Lind, J M Margison, T Cerny, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapyB H Lauterburg, T Nguyen, B Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristicsK Buser, F Joncourt, H J Altermatt, et al.
Helvetica Chirurgica Acta|June 1, 1989
[Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma]M Rentsch, T Cerny, J Richner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
Pageof 15